{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","metadata_created":"2019-01-21T15:51:50.495545","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-01-21T15:51:50.495553","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-01-21","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Maladies bactériennes invasives","pneumococcies invasives (SSAPI)","Éclosion d’infection à Shigella sonnei","Enterobacteriaceae","de Pseudomonas aeruginosa","du genre Acinetobacter spp","Stenotrophomonas maltophilia","paludisme RTS","S/AS01","Le vaccin RTS","S/AS01","Conférence de l'Association canadienne de santé publique","Conférence SIDA"],"en":["Invasive bacterial diseases","bacterial diseases","Invasive Pneumococcal Diseas","Shigella sonnei","Shigella sonnei in Montréal","Enterobacteriaceae","Pseudomonas aeruginosa","Acinetobacter spp","Stenotrophomonas maltophilia","malaria vaccine","RTS","S/AS01 vaccine","tetravalent dengue vaccine","Vaccine Research conference","Conference on Vaccine Research","AIDS Conference"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 42-4, le 7 avril 2016 : Maladies évitables par la vaccination","en":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ff6d8da4-e517-4b6b-a757-49775c36c1fe","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-4, le 7 avril 2016 : Maladies évitables par la vaccination","en":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases","language":["en"],"created":"2019-01-21T15:51:51.201375","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016.html","last_modified":null,"position":0,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1ac075f5-50fa-4ce0-966a-7c4aa9fb602d","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-4, le 7 avril 2016 : Maladies évitables par la vaccination","en":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases","language":["fr"],"created":"2019-01-21T15:51:51.201383","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016.html","last_modified":null,"position":1,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"id":"868b400a-f6a2-4340-87c9-efc55008e703","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-4, le 7 avril 2016 : Maladies évitables par la vaccination","en":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases","language":["en"],"created":"2019-01-21T15:51:51.201386","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-4/assets/pdf/16vol42_4-eng.pdf","last_modified":null,"position":2,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"id":"4dd81263-c6ce-4968-af62-84897b18384b","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-4, le 7 avril 2016 : Maladies évitables par la vaccination","en":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases","language":["fr"],"created":"2019-01-21T15:51:51.201388","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-4/assets/pdf/16vol42_4-fra.pdf","last_modified":null,"position":3,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"00f0cb5b-9e51-490e-b70d-25f6c426d973","related_relationship":"","name_translated":{"fr":"Les maladies bactériennes au Canada","en":"Bacterial Diseases in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bacterial Diseases in Canada","language":["en"],"created":"2019-01-21T15:51:51.201390","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases.html","last_modified":null,"position":4,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"84d558f0-9506-4af3-9799-91ba842474cd","related_relationship":"","name_translated":{"fr":"Les maladies bactériennes au Canada","en":"Bacterial Diseases in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Bacterial Diseases in Canada","language":["fr"],"created":"2019-01-21T15:51:51.201393","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination.html","last_modified":null,"position":5,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bb30ea35-5c9d-4b6a-80bc-bd7e43b9a11b","related_relationship":"","name_translated":{"fr":"Système de surveillance des pneumococcies invasives","en":"Outbreak of Shigella sonnei in Montréal’s ultra-Orthodox Jewish community, 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak of Shigella sonnei in Montréal’s ultra-Orthodox Jewish community, 2015","language":["en"],"created":"2019-01-21T15:51:51.201395","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-1.html","last_modified":null,"position":6,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"22df5d91-d20a-4717-bbfe-aff40dfbad00","related_relationship":"","name_translated":{"fr":"Système de surveillance des pneumococcies invasives","en":"Outbreak of Shigella sonnei in Montréal’s ultra-Orthodox Jewish community, 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak of Shigella sonnei in Montréal’s ultra-Orthodox Jewish community, 2015","language":["fr"],"created":"2019-01-21T15:51:51.201397","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-1.html","last_modified":null,"position":7,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"867c977a-c77e-4cc3-adcc-98e828ea0eb4","related_relationship":"","name_translated":{"fr":"Shigella sonnei à Montréal, 2015","en":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia","language":["en"],"created":"2019-01-21T15:51:51.201399","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-3.html","last_modified":null,"position":8,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"57bd5fae-104d-4f37-8827-d8169df3af65","related_relationship":"","name_translated":{"fr":"Shigella sonnei à Montréal, 2015","en":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia","language":["fr"],"created":"2019-01-21T15:51:51.201402","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-2.html","last_modified":null,"position":9,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"465ca5aa-128e-4aaa-8f2a-5ebaff520e44","related_relationship":"","name_translated":{"fr":"Isolats résistants de la famille des Enterobacteriaceae, de Pseudomonas aeruginos, du genre Acinetobacter spp. et de Stenotrophomonas maltophilia","en":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia","language":["en"],"created":"2019-01-21T15:51:51.201404","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-3.html","last_modified":null,"position":10,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"edbc8ff8-4e63-444c-900a-34ee7ca11738","related_relationship":"","name_translated":{"fr":"Isolats résistants de la famille des Enterobacteriaceae, de Pseudomonas aeruginos, du genre Acinetobacter spp. et de Stenotrophomonas maltophilia","en":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim recommendations for the reporting of extensively drug resistant and pan-drugresistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia","language":["fr"],"created":"2019-01-21T15:51:51.201406","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-3.html","last_modified":null,"position":11,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f7f63486-2b2a-41ed-8fb0-5e19e59c19f9","related_relationship":"","name_translated":{"fr":"Efficacité et innocuité du vaccin contre le paludisme RTS,S/AS01","en":"Efficacy and safety of RTS,S/AS01 malaria vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Efficacy and safety of RTS,S/AS01 malaria vaccine","language":["en"],"created":"2019-01-21T15:51:51.201409","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-4.html#a1","last_modified":null,"position":12,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"44d60e55-ea42-4a49-9e12-a15e34950a3a","related_relationship":"","name_translated":{"fr":"Efficacité et innocuité du vaccin contre le paludisme RTS,S/AS01","en":"Efficacy and safety of RTS,S/AS01 malaria vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Efficacy and safety of RTS,S/AS01 malaria vaccine","language":["fr"],"created":"2019-01-21T15:51:51.201411","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-4.html#a1","last_modified":null,"position":13,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b1c6b9e1-d8a2-44a7-9b6a-816677c7f31e","related_relationship":"","name_translated":{"fr":"Le vaccin RTS,S/AS01 continue de montrer une protection modeste","en":"The RTS,S/AS01 vaccine continues to show modest protection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The RTS,S/AS01 vaccine continues to show modest protection","language":["en"],"created":"2019-01-21T15:51:51.201413","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-4.html#a2","last_modified":null,"position":14,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b8fac6b2-f452-42ce-9784-8b89bd0f5ffe","related_relationship":"","name_translated":{"fr":"Le vaccin RTS,S/AS01 continue de montrer une protection modeste","en":"The RTS,S/AS01 vaccine continues to show modest protection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The RTS,S/AS01 vaccine continues to show modest protection","language":["fr"],"created":"2019-01-21T15:51:51.201415","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-4.html#a1","last_modified":null,"position":15,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1de29dad-943a-4298-ae54-b51f60f97f40","related_relationship":"","name_translated":{"fr":"Évaluation de l’innocuité du vaccin contre le charbon chez des jeunes de 18 à 20 ans","en":"Evaluation of anthrax vaccine safety in 18-20 year olds"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluation of anthrax vaccine safety in 18-20 year olds","language":["en"],"created":"2019-01-21T15:51:51.201417","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-4.html#a3","last_modified":null,"position":16,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e62b6288-7526-494c-9524-3c9039504d32","related_relationship":"","name_translated":{"fr":"Évaluation de l’innocuité du vaccin contre le charbon chez des jeunes de 18 à 20 ans","en":"Evaluation of anthrax vaccine safety in 18-20 year olds"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluation of anthrax vaccine safety in 18-20 year olds","language":["fr"],"created":"2019-01-21T15:51:51.201419","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-4.html#a1","last_modified":null,"position":17,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1246ba05-a154-4093-9ffb-fc0b4384564e","related_relationship":"","name_translated":{"fr":"Vaccin tétravalent à dose unique contre la dengue","en":"Single dose tetravalent dengue vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Single dose tetravalent dengue vaccine","language":["en"],"created":"2019-01-21T15:51:51.201422","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-4-april-7-2016/ccdr-volume-42-4-april-7-2016-vaccine-preventable-diseases-4.html#a4","last_modified":null,"position":18,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b371c816-bb28-468b-a4e0-116bc1948d9d","related_relationship":"","name_translated":{"fr":"Vaccin tétravalent à dose unique contre la dengue","en":"Single dose tetravalent dengue vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Single dose tetravalent dengue vaccine","language":["fr"],"created":"2019-01-21T15:51:51.201424","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-4-7-avril-2016/rmtc-volume-42-4-7-avril-2016-maladies-evitables-vaccination-4.html#a4","last_modified":null,"position":19,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b2399df9-8a94-4a26-8eef-bdef7259d774","related_relationship":"","name_translated":{"fr":" 21e Conférence internationale sur le SIDA (SIDA 2016).Durban, Afrique du Sud.","en":"21st International AIDS Conference (AIDS 2016). Durban, South Africa."},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"21st International AIDS Conference (AIDS 2016). Durban, South Africa.","language":["en"],"created":"2019-01-21T15:51:51.201426","url":"http://www.aids2016.org/","last_modified":null,"position":20,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2c7be151-cd9d-4376-a0b9-873fce2bc211","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"92875421-aca7-4936-97d5-bef1d0c2983a","related_relationship":"","name_translated":{"fr":" 21e Conférence internationale sur le SIDA (SIDA 2016).Durban, Afrique du Sud.","en":"21st International AIDS Conference (AIDS 2016). Durban, South Africa."},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"21st International AIDS Conference (AIDS 2016). Durban, South Africa.","language":["fr"],"created":"2019-01-21T15:51:51.201428","url":"http://www.aids2016.org/","last_modified":null,"position":21,"revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641","resource_type":"website"}],"place_of_publication":[],"num_resources":22,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2016-04-07 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"2c7be151-cd9d-4376-a0b9-873fce2bc211","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases","revision_id":"a77fa7ea-6cc5-498e-b6b6-96d80ae05641"}